Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Teva Gains to 4-Week High After U.S. Court Denies Motion
Teva Gains to 4-Week High After U.S. Court Denies Motion
Teva Gains to 4-Week High After U.S. Court Denies Motion
Submitted by
admin
on August 30, 2011 - 11:33am
Source:
Bloomberg
News Tags:
Teva Pharmaceuticals
patents
Copaxone
Mylan
MS
multiple sclerosis
Headline:
Teva Gains to 4-Week High After U.S. Court Denies Motion
Do Not Allow Advertisers to Use My Personal information
